ANDA 77330, held by Sun Pharm Inds. Octreotide Acetate.
As of Nov 16, 2026, ANDA 77330 (Octreotide Acetate), held by Sun Pharm Inds, was first approved by FDA on Mar 4, 2008, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 4, 2008 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Octreotide AcetateEQ 0.2MG BASE/ML ยท injectable;injection | Octreotide Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters